announcements
2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003
2009
YM BioSciences Merger : Supplementary Information 18 December 2009
Proposed Merger Presentation 18 December 2009
Adjournment of Annual General Meeting 2009 11 December 2009
Scheme Meeting for YM Merger 9 December 2009
Dosing in CYT387 clinical trial begins 24 November 2009
Announcement of Annual General Meeting 19 November 2009
Key Data Release on CYT997 10 November 2009
Update on merger with YM BioSciences 2 November 2009
Change of Registered Office and Principal Place of Business 30 October 2009
Cytopia Annual Report 2009 30 October 2009
Cytopia opens fourth clinical centre for CYT997 glioma study 19 October 2009
Resignation of Director 19 October 2009
Cytopia merger with Toronto-based YM Biosciences Inc 6 October 2009
Cytopia merger with YM Biosciences Inc Implementation Agreement 6 October 2009
Cytopia achieves grant for further patent for JAK2 program 30 September 2009
2009 Full year accounts 17 September 2009
Cytopia's CYT387 receives FDA clearance to start US Clinical Trials 4 September 2009
Preliminary Final Report August 2009 25 August 2009
Cytopia lodges IND for JAK2 inhibitor CYT387 23 June 2009
Cytopia secures key patents 16 June 2009
Cytopia moves focus to clinical stage cancer company 5 June 2009
Oral VDA CYT997 - Phase I clinical trial presentation at ASCO 29 May 2009
Cytopia cancer program reaches important milestone 26 May 2009
Cytopia presentation on VDA CYT997 at AACR conference 16 April 2009
Structure of protein involved in immune system and cancer solved 24 March 2009
Cytopia scientific presentation on JAK2 inhibitor program at ACSC 24 March 2009
Mailout to Progen shareholders 16 March 2009 16 March 2009
Cytopia shareholder group drives defeat of Progen merger plans 11 March 2009
Cytopia letter to Progen shareholders 25 February 2009
Progen concedes shareholder requisitioned meeting 19 February 2009
Cytopia and other Progen shareholders maintain call for meeting 9 February 2009
Cytopia half year report to 31 December 2008 9 February 2009
Cytopia concludes Phase I oral trial for CYT997 5 February 2009
Request for General Meeting of Progen Pharmaceuticals Ltd 28 January 2009
